Bibliothèque de la FMPO
Détail de l'auteur
Auteur Albert Sasson |
Documents disponibles écrits par cet auteur
Affiner la recherche Interroger des sources externes
Health Care, Food and Nutrition Opportubities and Challenges For the Life Sciences and Biotechnology / Albert Sasson
Titre : Health Care, Food and Nutrition Opportubities and Challenges For the Life Sciences and Biotechnology Type de document : texte imprimé Auteurs : Albert Sasson, Auteur ; Hassan II Academy of Sces and Technology, Auteur ; CGSS, Auteur Editeur : AGRI-BYS Année de publication : 2011 ISBN/ISSN/EAN : 978-9954-520-03-1 Langues : Français (fre) Catégories : Endocrinologie Résumé : Summarized Contents :
- Part one : Health Care : Between Innovation and Cost-Effectiveness
- Part Two : Fppd and Nutrition : A Contemporary Challenging Area for Biology, Medicicne and BiotechnologyHealth Care, Food and Nutrition Opportubities and Challenges For the Life Sciences and Biotechnology [texte imprimé] / Albert Sasson, Auteur ; Hassan II Academy of Sces and Technology, Auteur ; CGSS, Auteur . - [S.l.] : AGRI-BYS, 2011.
ISBN : 978-9954-520-03-1
Langues : Français (fre)
Catégories : Endocrinologie Résumé : Summarized Contents :
- Part one : Health Care : Between Innovation and Cost-Effectiveness
- Part Two : Fppd and Nutrition : A Contemporary Challenging Area for Biology, Medicicne and BiotechnologyExemplaires (4)
Code-barres Cote Support Localisation Section Disponibilité 6697 Endo 68 Livre Bibliothèque Endocrinologie Disponible 6698 Endo 68 Livre Bibliothèque Endocrinologie Disponible 6699 Endo 68 Livre Bibliothèque Endocrinologie Disponible 6700 Endo 68 Livre Bibliothèque Endocrinologie Disponible Medical Biotechnology : Current Achievements and Prospects. Another Colden ERA / Albert Sasson
Titre : Medical Biotechnology : Current Achievements and Prospects. Another Colden ERA Type de document : texte imprimé Auteurs : Albert Sasson, Auteur Editeur : Hassan II Academy of Sces and Technology Année de publication : 2016 Autre Editeur : The Academy of the Kingdom of Morocco ISBN/ISSN/EAN : 978-9954-520-13-0 Langues : Français (fre) Catégories : Biologie Résumé : Part one hughlights the currentconsiderable flow of financial resources towards medical biotechnology. We are acknowledging a real boom of the bioindustry and a "golden era of DNA". Such unprecedented situation does not seem to be a bubble that would burst, because the "science has never been so good and the pace of medical advences has never been so fast. Rocketing start-ups have been created and some of them have become big pharmas due to large initial venture capital investments and to the commercialization of their innovative drig. Also, there has been a frenzy of mergers and acquisitions in the pharmaceutical and medical-biotechnology sectors, as well as an increasing involvement of the giant information and communication technology groups (GAFAs) in life sciences and biomedecine. The latter are competing for dominance in the next era of computing and for harnessing unparalleled troves of data in order to offer new services, including the handling of patients personal data; they also want to seiz the opportunities arsing from the predictable great impacton biomedical and clinical research of the combination of human genomics with the wide-ranging applications of information and communication technologies. Part two deals with the current and foreseeable impact on human genomics of the ever faster and cheaper sequencing of genomes, as well as with genome editing and its derived implications for biomedical research, development and innovation. Some of the huge amount of data produced by genome sequencing are being correlated with diseases. Also, the soaring market of genetic tests designed for the large public reponds to requests from individuals and open sociatal debate. We have also moved from genome to genome editing or to gene surgery. The discoverey and rapid adoption and use, since 2013, of the CRISPR-Cas9 technique may have profound consequences on gene therapy and the cure of some genetic defects or diseases. However the majority of researchers call for a moratorium on any experiment that aims to edit the genome of a human embryo to be implanted in the womb with subsequent genetic modifications in the offspring. Investors, although cautious, have shown interest for the technology, ase well as for the current boom of synthetic biology. Part Three Reviews current achievements and prospects in mediacl biothechnology vaccins and vaccination issues, with emphasis on the vaccines against elbola, dengue, infleunza and papilloma viruses; towards eradicating tuberculosis, malaria (control of mosquito population); genetic and rere diseases; new weapons against cancer; cardiovascular diseases; diabetes / obesity; stem-cell therapies; and the development of precision medicine and of a genuine health care system. Medical Biotechnology : Current Achievements and Prospects. Another Colden ERA [texte imprimé] / Albert Sasson, Auteur . - [S.l.] : Hassan II Academy of Sces and Technology : [S.l.] : The Academy of the Kingdom of Morocco, 2016.
ISBN : 978-9954-520-13-0
Langues : Français (fre)
Catégories : Biologie Résumé : Part one hughlights the currentconsiderable flow of financial resources towards medical biotechnology. We are acknowledging a real boom of the bioindustry and a "golden era of DNA". Such unprecedented situation does not seem to be a bubble that would burst, because the "science has never been so good and the pace of medical advences has never been so fast. Rocketing start-ups have been created and some of them have become big pharmas due to large initial venture capital investments and to the commercialization of their innovative drig. Also, there has been a frenzy of mergers and acquisitions in the pharmaceutical and medical-biotechnology sectors, as well as an increasing involvement of the giant information and communication technology groups (GAFAs) in life sciences and biomedecine. The latter are competing for dominance in the next era of computing and for harnessing unparalleled troves of data in order to offer new services, including the handling of patients personal data; they also want to seiz the opportunities arsing from the predictable great impacton biomedical and clinical research of the combination of human genomics with the wide-ranging applications of information and communication technologies. Part two deals with the current and foreseeable impact on human genomics of the ever faster and cheaper sequencing of genomes, as well as with genome editing and its derived implications for biomedical research, development and innovation. Some of the huge amount of data produced by genome sequencing are being correlated with diseases. Also, the soaring market of genetic tests designed for the large public reponds to requests from individuals and open sociatal debate. We have also moved from genome to genome editing or to gene surgery. The discoverey and rapid adoption and use, since 2013, of the CRISPR-Cas9 technique may have profound consequences on gene therapy and the cure of some genetic defects or diseases. However the majority of researchers call for a moratorium on any experiment that aims to edit the genome of a human embryo to be implanted in the womb with subsequent genetic modifications in the offspring. Investors, although cautious, have shown interest for the technology, ase well as for the current boom of synthetic biology. Part Three Reviews current achievements and prospects in mediacl biothechnology vaccins and vaccination issues, with emphasis on the vaccines against elbola, dengue, infleunza and papilloma viruses; towards eradicating tuberculosis, malaria (control of mosquito population); genetic and rere diseases; new weapons against cancer; cardiovascular diseases; diabetes / obesity; stem-cell therapies; and the development of precision medicine and of a genuine health care system. Exemplaires (4)
Code-barres Cote Support Localisation Section Disponibilité 6693 Biologie 52 Livre Bibliothèque Biologie Disponible 6694 Biologie 52 Livre Bibliothèque Biologie Disponible 6695 Biologie 52 Livre Bibliothèque Biologie Disponible 6696 Biologie 52 Livre Bibliothèque Biologie Disponible